Rhenman & Partners Asset Management AB

Bedrift Dele, %
INmune Bio, Inc. INmune Bio, Inc. 0.67
Five Prime Therapeutics, Inc. Five Prime Therapeutics, Inc. 0.54

Kategori Mengde
Healthcare 2